Get started
Author

Gosford A. Sawyerr

Observed names: G. Sawyerr, Gosford Sawyerr, Sawyerr, Gosford, Sawyerr, Gosford A.
OpenAlex ID: A5087638975
Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study
2011 · Deborah J. Steiner, Steve Sitar, et al. · Journal of Pain and Symptom Management · 110
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial
2022 · Andra-Rodica Balanescu, Gustavo Citera, et al. · Annals of the Rheumatic Diseases · 73
PDF
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection
2000 · Joseph J. Eron, Ellen S. Yetzer, et al. · AIDS · 62
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome
2001 · Ralph A. DeMasi, Neil M. Graham, et al. · Advances in Therapy · 53
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program
2022 · Gary R Lichtenstein, Brian Bressler, et al. · Inflammatory Bowel Diseases · 39
PDF
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance
2023 · George A. Karpouzas, Zoltán Szekanecz, et al. · Therapeutic Advances in Musculoskeletal Disease · 24
PDF
Pos0519 Relationship Between Disease Activity and Major Adverse Events in Patients With Rheumatoid Arthritis on Tofacitinib or Tnf Inhibitors: a Post Hoc Analysis of Oral Surveillance
2022 · G. Karpouzas, Z. Szekanecz, et al. · Annals of the Rheumatic Diseases · 12
PDF
Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
2022 · Roy Fleischmann, Boulos Haraoui, et al. · Rheumatology and Therapy · 3
PDF
Impact of Concomitant Methotrexate Use and Prior Biologic Disease‐Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial
2025 · Nicolino Ruperto, Daniel J. Lovell, et al. · ACR Open Rheumatology · 1
PDF
Pos0086 Analysis of Disease Activity Measures in the Context of a Methotrexate Withdrawal Study Among Patients With Rheumatoid Arthritis Treated With Tofacitinib 11 Mg Once Daily + Methotrexate: Post Hoc Analysis of Data From Oral Shift
2021 · R. Fleischmann, B. Haraoui, et al. · Annals of the Rheumatic Diseases · 1
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa
2016 · Adam J. Ericsen, Michael Lauck, et al. · 1
P-105. Safety and Immunogenicity of BNT163, a Trivalent mRNA HSV Vaccine Candidate for Genital Herpes
2026 · Akira A Shishido, Pablo Tebas, et al. · Open Forum Infectious Diseases
Pos0443 Exploring Novel Tenosynovitis and Combined Inflammation Imaging Outcomes: Results From a Randomised Controlled Trial in Early Rheumatoid Arthritis
2021 · P.G. Conaghan, M. Østergaard, et al. · Annals of the Rheumatic Diseases
Su1426 Effectiveness of Simeprevir-Containing Regimens Among Patients With Chronic Hepatitis C Virus in Various US Practice Settings: The SONET Study
2016 · Imtiaz Alam, Kimberley Brown, et al. · Gastroenterology
Effectiveness of Simeprevir-Containing Regimens among Patients with Chronic Hepatitis C Virus in Various Us Practice Settings: The Sonet Study
2016 · I. Alam, K. Brown, et al. · Journal of Hepatology
Works count: 19
Citation count: 379
H-index: 7
I10-index: 7
Year
Topic
Type